Intec Pharma Ltd. announced that Zeev Weiss, Chief Executive Officer and a Director of the company, is resigning from both positions effective immediately to pursue other professional opportunities. Mr. Weiss will serve as a clinical and business development consultant to Intec Pharma. The company's Board of Directors have appointed Giora Carni, a Director since 2006 and Chief Executive Officer of Intec Pharma from 2006 to 2014, as Interim Chief Executive Officer while a search for a new Chief Executive Officer has been initiated.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 USD | +3.12% | +6.44% | +22.16% |
May. 08 | Indaptus Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 14 | Top Premarket Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.16% | 18.36M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- INDP Stock
- News Indaptus Therapeutics, Inc.
- Intec Pharma Ltd. Announces Management Changes